Olympus increases endoscopy sales, monitors supply chain issues
The Covid-19 pandemic challenges are easing up for Olympus, but the company still predicts uncertain supply chains, higher costs and trading challenges between the US and China. Still, endoscopy sales have gone well at the Japanese medtech giant.
by ULRICH QUISTGAARD, translated by daniel pedersen
Japanese Olympus has added 22 percent to its revenue in the first nine months of the financial year, as reported in the medtech company’s third quarter figures.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Olympus upgrades after Covid-19 recovery
For subscribers
